Treatment with CHIR99021, a Wnt/β-catenin activator, restored both invasion (Figure 5C) and mesenchymal marker expression (Figure 5D) in TRIM46-depleted ovarian cancer cells. Here, TRIM46 is linked to ovarian cancer.